Merck

Merck Millipore, Celares, to Offer Pegylation Services

Johnson Matthey Acquires Pharmorphix

Merck and Pfizer Get FDA Orphan Drug Status

Merck to Close on Sigma-Aldrich in Q4

Merck and Tridonic in License Agreement for Silicate Phosphors

Merck KGaA Streamlines Healthcare Management

Merck Serono Expands Biopharmaceuticals Lab

UK Health Agency Blesses Merck Cancer Drug

Topics • Strategy

Global Chemicals Markets Still Volatile and Challenging

Topics • Strategy

Significant Value Creation

Germany’s Merck Wins Last Antitrust Nod for Sigma-Aldrich

Codexis Licenses CodeEvolver Technology to US Merck

Germany’s Merck to Mentor Scheme Start-ups

Platform Offers $2.3 Billion for Alent

Merck KGaA to Buy all of Quantum Materials Firm

Germany’s Merck Lays Cornerstone for OLED Plant

EU Approves Merck KGaA’s Takeover of Sigma-Aldrich

Topics • Technology

Quality and Efficiency in Pharma Manufacturing

Merck Millipore Buys Rights to Singulex's SMC Technology

Merck Appoints Udit Batra to Head Combined Life Science Business

Oschmann Set to Become Merck KGaA's CEO

Topics • Strategy

Drugs Industry Battered by Currency and Competition

Merck Serono and Illumina in Oncology Diagnostics Pact

Baumann Says He’ll Fight to Keep Bayer Independent

Germany’s Merck and FlexEnable Find Plastic LCD

Merck KGaA Places €1.5 Billion Bond for Sigma-Aldrich Deal

Sigma-Aldrich Shareholders Approve Takeover by Merck

Germany's Merck Plans to Expand in Consumer Health

Germany's Merck Commissions Biomass Power Plant in Goa

Germany to Introduce Quotas for Women on Supervisory Boards

Merck KGaA and Pfizer to Join Forces on Oncology Drug

Sigma-Aldrich to Acquire Reagents Maker Cell Marque

Moody Reviews German Merck’s Credit Rating

Merck Serono and Sutro to Collaborate on ADCs

Merck KGaA to Buy Sigma-Aldrich for $17 billion

150 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing